News
Register to attend a free NIH webinar to learn about a new non-opioid small molecule for treating opioid use and substance use disorders by selectively targeting the dopamine D3 receptor. Dr. Amy Newman and her team at the National Institutes of Health’s National Institute on Drug Abuse (NIDA)
Inventors at the National Cancer Institute (NCI) have created a tool for developing new targeted therapies or enhancing patient stratification in transcriptomic multi-arm trials. This tool, named SELECT, uses a computational, precision-oncology framework that uses the tumor’s whole transcriptome to
Are you interested in licensing an automated digital pathology device? The National Cancer Institute (NCI) is seeking licensees to develop an automated digital pathology device that could be used for biopsy sample processing and applicable to diagnoses of various disease indications, including
The NIH Technology Transfer Community is made up of a wide variety of dedicated professionals. OTT would like to highlight and give special thanks to a few of them. Karen Rogers was the Acting Director of OTT from 2015-2020. This past year she won an Office of the Director award for her outstanding